SEC Form 4 · accession 0001144204-16-126314
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Preti
Officer — See Remarks · Director
Period of report
Sep 29, 2016
Accepted (ET)
Sep 30, 2016 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $4.77 | Sep 29, 2016 | A | 20,894 | A | Sep 29, 2016 | Sep 29, 2026 | Common Stock | 20,894 | 20,894 | D |
Explanation of responses
- F1These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.
Remarks
Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer.